Graematter, Inc.
Graematter has developed and patented an FDA-related Regulatory Intelligence System.
- Stage Full Product Ready
- Industry IT Services
- Location St. Louis, MO, USA
- Currency USD
- Employees 6
- Website graematter.com
Company Summary
Graematter has created a proprietary information analytics system that consolidates information from numerous FDA sources into a single database with unique search capabilities. The system helps assure that regulatory staffs will find the critical information needed to develop the shortest, lowest cost pathway to FDA approval. In addition, the Graematter System typically reduces the search time from a week to less than two hours.
Team
-
Merle SymesCEO
- President & CEO Ulrich Medical (spine implants)
- President & CEO, Provenance Group (consultant and equity partner in early stage ventures)
- VP External Technology – Bausch & Lomb
MBA – Wharton
BS –Chemical Engineering -
Melissa WalkerPresident/CTO and Founder
- Sr. VP Regulatory, Quality, & Compliance – Stereotaxis, Inc.
- Exec Director, Global Regulatory Affairs – Bausch & Lomb
- Adjunct Professor – Washington University
- Fellow – Regulatory Affairs Professionals Society
MS Zoology, BS Biology & Animal Science – East Texas State University -
Peggy StohrCFO
- CFO EndoStim and Pulse Therapeutics
- CFO Yurbuds
- VP Administration & Controller – Stereotaxis, Inc.
CPA
MBA – Washington University MS & BS – Accounting
Advisors
-
Andrew Hoyne - PolsinelliLawyerUnconfirmedStone CarlieAccountantUnconfirmed
Previous Investors
-
BioGeneratorUnconfirmedMissouri Technology CorporationUnconfirmedSt. Louis County Helix FundUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.